Octave Bioscience Expands Leadership Team with Appointment of Kirk Stockwood Senior Vice President, Commercial

Octave Bioscience, Inc., a commercial stage precision medicine company pioneering biomarker driven solutions for multiple sclerosis, Parkinson's disease and other neurodegenerative diseases today ...

What Analysts Think Is Changing The Story For Octave Specialty Group (OSG)

Analysts recently updated their narrative on Octave Specialty Group, trimming the price target to US$15 while leaving the ...
The Pharma Letter

Octave Bioscience expands leadership team

US commercial stage precision-care company Octave Bioscience has announced the appointment of Kirk Stockwood as senior vice ...
Insurance Insider

Beat-rebranded Octave launches Statera Managing Agency at Lloyd’s

Octave Ventures, rebranded Beat Capital Partners, has received approval from Lloyd's to launch Statera Managing Agency and ...
Business Wire

Octave Bioscience Announces $35M Series C Financing to Accelerate Commercial Momentum

MENLO PARK, Calif.--(BUSINESS WIRE)--Octave Bioscience, Inc., a commercial stage precision care company that is pioneering a new standard for managing multiple sclerosis (MS) and other ...
National Catholic Register

Pentecost Octave — Where Art Thou?

On the Monday after Pentecost in 1970, so the story goes, Blessed Pope Paul VI rose early and went to his chapel to celebrate Mass. Instead of the red vestments he expected, green ones were laid out ...